Quantitative Investment Management, LLC - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 193 filers reported holding NPS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.

Quarter-by-quarter ownership
Quantitative Investment Management, LLC ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2014$584,000
-41.9%
17,700
-47.3%
0.10%
+118.8%
Q1 2014$1,005,000
+145.7%
33,600
+148.9%
0.05%
+23.1%
Q4 2013$409,000
-1.4%
13,500
-50.9%
0.04%
-46.6%
Q2 2013$415,00027,5000.07%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Consonance Capital Management LP 1,839,263$27,791,0009.88%
Broadfin Capital, LLC 1,696,754$25,638,0005.02%
HARVEY CAPITAL MANAGEMENT INC 1,057,800$15,982,0004.96%
ArrowMark Colorado Holdings LLC 578,750$8,745,0002.35%
FCG ADVISORS, LLC 140,805$2,128,0001.73%
EMERALD MUTUAL FUND ADVISERS TRUST 600,471$9,073,0001.54%
OAK RIDGE INVESTMENTS LLC 2,782,714$42,047,0001.32%
Lisanti Capital Growth, LLC 139,340$2,510,0001.20%
EMERALD ADVISERS, LLC 1,193,198$18,029,0001.10%
SECTORAL ASSET MANAGEMENT INC 2,302,428$34,790,0001.03%
View complete list of NPS PHARMACEUTICALS INC shareholders